Table 1.
ALT ± SD (U/l) among the studied groups after 3 weeks, 6 weeks, and 9 weeks.
| ALT (U/l) | ALT (U/l) (3 weeks) | ALT (U/l) (6 weeks) | ALT (U/l) (9 weeks) | Paired t-test | ||
|---|---|---|---|---|---|---|
| P 1 | P 2 | P 3 | ||||
| Control | 25.40 ± 3.3 | 26.70 ± 3.19 | 25.20 ± 3.01 |
t
1 = 1.22 P1 = 0.25 |
t
2 = 0.11 P2 = 0.91 |
t
3 = 0.89 P3 = 0.39 |
| CCl4 | 63.90 ± 20 | 82.30 ± 11.87 | 66.00 ± 18.92 |
t
1 = 2.45 P1 = 0.04∗ |
t
2 = 0.18 P2 = 0.86 |
t
3 = 2.08 P3 = 0.06 |
| Free media | 62.30 ± 19.7 | 81.40 ± 13.78 | 64.60 ± 18.07 |
t
1 = 2.05 P1 = 0.07 |
t
2 = 0.29 P2 = 0.78 |
t
3 = 2.22 P3 = 0.05∗ |
| CCl4+Nilotinib | 43.00 ± 14 | 51.70 ± 13.27 | 51.20 ± 11.22 |
t
1 = 3.56 P1 = 0.006∗ |
t
2 = 1.32 P2 = 0.22 |
t
3 = 0.09 P3 = 0.93 |
| CCl4+stem cell exosomes | 55.90 ± 11.5 | 54.20 ± 10.42 | 38.30 ± 6.49 |
t
1 = 0.33 P1 = 0.75 |
t
2 = 4.39 P2 = 0.002∗ |
t
3 = 4.77 P3 = 0.001∗ |
| CCl4+stem cell exosomes+Nilotinib | 30.50 ± 6.3 | 31.10 ± 7.70 | 29.00 ± 8.95 |
t
1 = 0.19 P1 = 0.85 |
t
2 = 0.46 P2 = 0.65 |
t
3 = 0.99 P3 = 0.34 |
| ANOVA test | 13.87 | 37.81 | 19.78 | — | — | — |
| P value | <0.001∗ | <0.001∗ | <0.001∗ | |||